News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
37–72
Matches
606
Sources here
19
Companies here
16
Search results Stored financial headlines

Active search

606 matching headlines

Ticker or company: SQMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Z Squared CEO to Shareholders: "The Scarcest Thing in AI Is Not Chips. It Is Power."

The CEO of Z Squared, an investment firm, communicated to shareholders that the primary bottleneck for artificial intelligence development is not the availability of chips, but rather the access to sufficient power. This highlights a critical and often overlooked infrastructure challenge for the rapidly …

ZSQR main company
Sharemaestro market context Price below Trend Line 52 weeks -70.7% · Next-week setup negative 40.3% ZSQR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

LAES Stock Climbs As SEALSQ Flags Quantum Growth Inflection

SEALSQ Corp. (LAES) stock has climbed by 7.39% due to heightened investor optimism surrounding its strategic developments and strong financial performance. The company reported approximately 120% year-over-year revenue growth in the first half of 2026, supported by significant liquidity and a substantial commercial pipeline. …

LAES main company
Sharemaestro market context Price below Trend Line 52 weeks +8.7% · Next-week setup negative 44.0% LAES stored weekly price path from 22 Aug 2025 to 14 Aug 2026

T. Rowe Price Investment Management (MSGS) discloses 5.6% ownership in Madison Square Garden Sports

T. Rowe Price Investment Management has reported a 5.6% beneficial ownership stake in Madison Square Garden Sports Corp. (MSGS), totaling 1,096,758 shares. The firm holds sole voting power over 1,074,218 shares and sole dispositive power over all 1,096,758 shares, as detailed in a Schedule …

MSGS main company
Sharemaestro market context Trend signal active 52 weeks +105.0% · Next-week setup positive 56.2% MSGS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Madison Square Garden Ent. (MSGE) stake at 13.1% held by Ariel

Ariel Investments, LLC has filed an amended Schedule 13G, disclosing a beneficial ownership of 5,302,754 shares of Madison Square Garden Entertainment Corp (MSGE) Class A common stock, representing 13.1% of the class as of June 30, 2026. Ariel holds sole voting power over 4,728,858 …

MSGE main company
Sharemaestro market context Trend signal active 52 weeks +117.2% · Next-week setup positive 63.2% MSGE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Z Squared targets 100 MW AI-ready power capacity via acquisitions, focusing on power-first strategy and disciplined scaling.

Z Squared Inc. aims to achieve 100 megawatts of AI-ready power capacity in the U.S. through strategic acquisitions of power-rich, grid-connected sites, starting with Paradox Data's Union County campus in Arkansas. The company plans to fund its expansion through stock issuance without incurring debt, …

ZSQR main company
Sharemaestro market context Price below Trend Line 52 weeks -70.7% · Next-week setup negative 40.3% ZSQR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Townsquare Media (TSQ) stake of 824,004 shares disclosed in 13G/A

American Century Investment Management, Inc., American Century Companies, Inc., and the Stowers Institute for Medical Research have filed an amended 13G/A report disclosing a beneficial ownership of 824,004 shares of Townsquare Media (TSQ) Class A Common Stock, representing 4.9% of the class. The group …

TSQ main company
Sharemaestro market context Price below Trend Line 52 weeks -9.6% TSQ stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Z Squared outlines power-first AI infrastructure strategy By Investing.com

Z Squared Inc. has announced a strategic shift towards acquiring power-connected sites to convert into AI infrastructure. The company recently signed an agreement to acquire Paradox Data and its Union County campus, which already has 8 megawatts of energized capacity and aims for up …

ZSQR main company
Sharemaestro market context Price below Trend Line 52 weeks -70.7% · Next-week setup negative 40.3% ZSQR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Palmer Square Capital BDC Inc (PSBD) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Palmer Square Capital BDC Inc (PSBD), detailing its current price momentum score, support and resistance levels, and a summary of various technical indicators and moving averages. As of the report, PSBD has a momentum score of 3.31 …

PSBD main company
Sharemaestro market context Price above Trend Line 52 weeks -18.2% PSBD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

BMS welcomes new multiple myeloma drug as generics batter current portfolio

Bristol Myers Squibb (BMS) received accelerated FDA approval for Zenbexus (iberdomide) for multiple myeloma, offering a new revenue stream as generics severely impact sales of its existing drugs, Revlimid and Pomalyst. Zenbexus is projected to achieve over $1 billion in annual earnings by 2031, …

BMY main company
Sharemaestro market context Trend signal active 52 weeks +38.1% BMY stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Oksenholt Capital Challenges Pershing Square’s Discounted Freddie Mac Valuation

The same business deserves the same multiple. On the evidence, Freddie may deserve more. SCOTTSDALE, Ariz., August 14, 2026--(BUSINESS WIRE)--Oksenholt Capital Management LLC today released a valuation analysis challenging Pershing Square's decision to value Freddie Mac (FMCC) at a materially lower earnings multiple than …

PS main company
Sharemaestro market context Stored weekly price path 16 weeks +7.5% · Next-week setup negative 33.8% PS stored weekly price path from 1 May 2026 to 14 Aug 2026

Bristol Myers Squibb announces new $2.3bn campus in the US

Bristol Myers Squibb has announced a new $2.3 billion multi-modal manufacturing campus in Houston, Texas, creating nearly 500 skilled jobs. This investment is part of BMS's $40 billion commitment to the US, aiming to accelerate the delivery of next-generation medicines. The campus's modular design …

BMY main company
Sharemaestro market context Trend signal active 52 weeks +38.1% BMY stored weekly price path from 22 Aug 2025 to 14 Aug 2026

GameSquare Holds 15,080 ETH, Discloses $25.9M in Total Assets

Nasdaq-listed media and entertainment company GameSquare (GAME) announced it held 15,080 Ethereum (ETH) as of June 30, with total assets amounting to approximately $25.9 million, including ETH, other altcoins, and cash. This disclosure highlights a growing trend of public companies investing in digital assets …

GAME main company
Sharemaestro market context Price above Trend Line 52 weeks -52.7% · Next-week setup negative 41.7% GAME stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Madison Square Garden Q4 Earnings Call Highlights

This article first appeared on GuruFocus. Total Revenues (FY2026): Approximately $1.2 billion. Adjusted Operating Income (FY2026): Nearly $59 million. Total Revenues (Q4 FY2026): $278.7 million, up from $204 million in the prior year period. Event-Related Revenues (Q4 FY2026): $200.7 million, an increase of 43% …

MSGS main company
Sharemaestro market context Trend signal active 52 weeks +105.0% · Next-week setup positive 56.2% MSGS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

How Investors Are Reacting To Intercontinental Exchange (ICE) Pershing Stake And Bond Issuance Momentum

In August 2026, Intercontinental Exchange, Inc. completed several fixed-income offerings totaling about US$3.73 billion in callable senior unsecured and subordinated notes with fixed coupons, alongside reporting strong July trading volumes and open interest across key asset classes. The disclosure that Pershing Square has built …

PS main company
Sharemaestro market context Stored weekly price path 16 weeks +7.5% · Next-week setup negative 33.8% PS stored weekly price path from 1 May 2026 to 14 Aug 2026

Is the Reported $400 Billion AstraZeneca-Bristol Myers Squibb Megamerger a Slam Dunk -- or a Disaster Waiting to Happen?

Key Points Earlier this month, AstraZeneca and Bristol Myers Squibb became the subject of merger rumors. Investors reacted negatively to the rumors, even if on paper such a deal would create an oncology-focused big pharma powerhouse worth around $400 billion. Considering regulatory uncertainty and …

BMY main company BMY main company BMY main company BMYS main company BRM main company
Sharemaestro market context Trend signal active 52 weeks +58.2% · Next-week setup positive 55.1% BMY stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Barclays PLC discloses 1,837,155-share MSGE stake in Madison Square Garden Entert (MSGE)

Barclays PLC has filed an amended Schedule 13G, disclosing a beneficial ownership of 1,837,155 shares in Madison Square Garden Entertainment Corp. (MSGE), which represents 4.54% of the class. The filing specifies that Barclays PLC holds sole voting and dispositive power over 1,815,732 shares, and …

MSGE main company
Sharemaestro market context Trend signal active 52 weeks +117.2% · Next-week setup positive 63.2% MSGE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Madison Square Garden Sports Submits 10-K for Fiscal 2026 Detailing Potential Rangers and Knicks Spin-Off

Madison Square Garden Sports Corp. filed its Annual Report on Form 10-K for the fiscal year ending June 30, 2026, outlining plans for a potential spin-off to separate the New York Rangers and New York Knicks into two independent publicly traded companies. The board …

MSGS main company
Sharemaestro market context Trend signal active 52 weeks +105.0% · Next-week setup positive 56.2% MSGS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

U.S. FDA Grants Accelerated Approval to Bristol Myers Squibb's First CELMoD Therapy ZENBEXUS™, in Combination with Daratumumab and Hyaluronidase-fihj and Dexamethasone (ZDd) for Patients with Multiple Myeloma, as Early as First Relapse

Bristol Myers Squibb announced that the U.S. FDA has granted accelerated approval for ZENBEXUS™ (iberdomide) in combination with daratumumab and hyaluronidase-fihj and dexamethasone (ZDd) for adult patients with multiple myeloma who have received at least one prior line of therapy. This approval, based on …

BMY main company BMY main company BMY main company BMYS main company BRM main company
Sharemaestro market context Trend signal active 52 weeks +58.2% · Next-week setup positive 55.1% BMY stored weekly price path from 22 Aug 2025 to 14 Aug 2026

SEALSQ reports 120% revenue growth in first half of 2026

SEALSQ Corp (NASDAQ: LAES) announced preliminary unaudited revenue of approximately $11 million for the first half of 2026, marking a 120% growth compared to the same period in 2025. The company also reaffirmed its full-year 2026 revenue guidance, anticipating 50% to 100% growth over …

LAES main company
Sharemaestro market context Price below Trend Line 52 weeks +8.7% · Next-week setup negative 44.0% LAES stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Z Squared Inc. 2Q 2026: Revenue $1.58M, Net loss $13.72M, EPS ($0.28) — 10-Q Summary

Z Squared Inc. (ZSQR) reported its second-quarter 2026 results, showing $1.58 million in revenue and a net loss of $13.72 million, resulting in a loss per share of $0.28. This performance follows the company's recent launch of crypto-mining operations and a strategic pivot from …

ZSQR main company
Sharemaestro market context Price below Trend Line 52 weeks -70.7% · Next-week setup negative 40.3% ZSQR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context